The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Arno Therapeutics (Inst)
Safety and pharmacokinetic (PK) results from phase 1 of an ongoing phase 1-2 study of onapristone (ONA) in patients (pts) with progesterone receptor (PR)-expressing cancers.
 
Antoine Italiano
Research Funding - Arno Therapeutics (Inst)
 
Jacques Bonneterre
Research Funding - Arno Therapeutics (Inst)
 
Andrea Varga
Research Funding - Arno Therapeutics (Inst)
 
Keyvan Rezai
Consulting or Advisory Role - Arno Therapeutics
 
Mario Campone
Research Funding - Arno Therapeutics (Inst)
 
Anne Floquet
Consulting or Advisory Role - MSD Oncology; Roche
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche; Vifor Pharma
 
Alexandra Leary
No Relationships to Disclose
 
Dominique Berton-Rigaud
No Relationships to Disclose
 
Marie-Paule Sablin
No Relationships to Disclose
 
Anne Lesoin
No Relationships to Disclose
 
Francois Marc Lokiec
Consulting or Advisory Role - Arno Therapeutics
 
Catherine Lhommé
No Relationships to Disclose
 
Alice Susannah Bexon
Consulting or Advisory Role - Arno Therapeutics
Travel, Accommodations, Expenses - Arno Therapeutics
 
Erard M. Gilles
Consulting or Advisory Role - Arno Therapeutics
Patents, Royalties, Other Intellectual Property - Arno Therapeutics
 
Joseph Bisaha
Employment - Arno Therapeutics
Leadership - Arno Therapeutics
Stock and Other Ownership Interests - Arno Therapeutics
Travel, Accommodations, Expenses - Arno Therapeutics
 
Alexander Zukiwski
Employment - Arno Therapeutics
Leadership - Arno Therapeutics
Stock and Other Ownership Interests - Arno Therapeutics
Patents, Royalties, Other Intellectual Property - Arno Therapeutics
Travel, Accommodations, Expenses - Arno Therapeutics
 
Paul H. Cottu
Research Funding - Arno Therapeutics (Inst)